Clinical Trial Update: PARACHUTE III Pressure Volume Loop Sub-Study

View source ↗

Summary

The PARACHUTE III pressure-volume loop sub-study sponsored by CardioKinetix has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• PARACHUTE III

Snippet

Sponsor: CardioKinetix, Inc | Conditions: Heart Failure, Myocardial Infarction | Status: TERMINATED